Gastroparesis Trial, Recruiting (NCT07717554)

Gastroparesis Trial, Recruiting NCT07717554 Sponsor: Ohio State University Condition: Gastroparesis

Printed from Voxsanity (voxsanity.com.au) — NCT07717554 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gastroparesis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with either type 1 or type 2 diabetes
People who have been diagnosed with gastroparesis (a condition where the stomach empties more slowly than normal), confirmed by a 4-hour stomach emptying test showing more than 10% of food still remaining in the stomach after 4 hours — and this test must have been done before joining the study
People who are currently experiencing at least moderate symptoms of gastroparesis

Who may not be able to join:

People with severe depression or severe anxiety, as identified through a screening questionnaire
People with active inflammatory bowel disease
People who have had abdominal surgery within the last 3 months
People with serious ongoing health conditions — such as advanced heart or lung disease — that could make it difficult to take part in a yoga-based program
People who are currently pregnant or breastfeeding (based on self-report)
People who have been practising yoga more than once a week in the last 6 months
People who are currently receiving treatment for any type of cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Subhankar CHAKRABORTY, MD, Ph.D., Ohio State University

Phone: 614-293-6255'

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07717554

Sponsor: Ohio State University

Phase: Not Applicable

Status: Recruiting

Condition: Gastroparesis

Trial contact: 614-293-6255'

More information: https://clinicaltrials.gov/study/NCT07717554

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with either type 1 or type 2 diabetes
People who have been diagnosed with gastroparesis (a condition where the stomach empties more slowly than normal), confirmed by a 4-hour stomach emptying test showing more than 10% of food still remaining in the stomach after 4 hours — and this test must have been done before joining the study
People who are currently experiencing at least moderate symptoms of gastroparesis

Who may not be able to join:

People with severe depression or severe anxiety, as identified through a screening questionnaire
People with active inflammatory bowel disease
People who have had abdominal surgery within the last 3 months
People with serious ongoing health conditions — such as advanced heart or lung disease — that could make it difficult to take part in a yoga-based program
People who are currently pregnant or breastfeeding (based on self-report)
People who have been practising yoga more than once a week in the last 6 months
People who are currently receiving treatment for any type of cancer

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ohio State University

Registry

ClinicalTrials.gov

Start date

17 July 2026

Est. completion

16 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Gastroparesis Symptoms; Physical and Mental Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov